Data as of Nov 21
| +0.17 / +1.24%|
The 12 analysts offering 12-month price forecasts for Ironwood Pharmaceuticals Inc have a median target of 13.75, with a high estimate of 22.00 and a low estimate of 9.00. The median estimate represents a -0.65% decrease from the last price of 13.84.
The current consensus among 12 polled investment analysts is to Hold stock in Ironwood Pharmaceuticals Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.